Promotion of Breastfeeding Intervention Trial (PROBIT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01561612 |
Recruitment Status :
Completed
First Posted : March 23, 2012
Last Update Posted : October 10, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Effect of Breastfeeding on Maternal and Child Health Outcomes | Behavioral: Breastfeeding promotion and support | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 17046 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Breastfeeding Promotion RCT and Child Metabolic Syndrome |
Study Start Date : | June 1996 |
Actual Primary Completion Date : | December 1998 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention
Breastfeeding promotion according to World Health Organization's Baby Friendly Hospital Initiative
|
Behavioral: Breastfeeding promotion and support
Breastfeeding promotion and support according to the World Health Organization's Baby Friendly Hospital Initiative |
No Intervention: Control
Usual care
|
- Gastrointestinal tract infection [ Time Frame: 12 months of age ]Occurrence of 1 or more episodes of gastrointestinal tract infection
- Maternal adiposity [ Time Frame: 6.5 and 11.5 years postpartum ]
- Child adiposity [ Time Frame: Throughout childhood ]
- asthma [ Time Frame: 6.5 and 16 years ]
- cognition [ Time Frame: 6.5 and 16 years ]
- dental caries [ Time Frame: 6.5 years ]
- child behavior [ Time Frame: 6.5 years ]
- vision [ Time Frame: 16 years ]
- lung function [ Time Frame: 16 years ]
- IGF-1 [ Time Frame: Age 11.5 years ]IGF from dried bloodspots
- child height [ Time Frame: throughout childhood ]Research measures of length/height
- adiponectin [ Time Frame: age 11.5 years ]adiponectin from dried bloodspot
- Apo A1 [ Time Frame: Child age 11.5 years ]Apo A1 in dried bloodspots
- glucose [ Time Frame: child age 11.5 years ]fingerstick glucose measured by glucometer
- insulin [ Time Frame: child age 11.5 years ]insulin measured on dried blood spots
- Apo B [ Time Frame: Child age 11.5 years ]Apo B measured in dried blood spots
- Child blood pressure [ Time Frame: throughout childhood ]Research measures of blood pressure at ages 6.5, 11.5 and 16 years
- Maternal blood pressure [ Time Frame: 11.5 years postpartum ]Research measure of maternal blood pressure
- Child metabolic syndrome [ Time Frame: Age 11.5 years ]
- Child growth [ Time Frame: Throughout childhood ]Growth in weight, length, weight for length, BMI, and other measures
- Respiratory tract infections [ Time Frame: to age 12 months and throughout childhood ]Number of respiratory infections, from review of medical record
- Atopic Eczema [ Time Frame: Throughout childhood ]Eczema from review of medical record, parent report,and direct examination
- Atopy [ Time Frame: Age 6.5 years ]Skinprick tests for allergy
- Eating Attitudes [ Time Frame: Age 11.5 years ]Children's Eating Attitudes Test (ChEAT) Questionnaire

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Birth at one of 34 Maternity Hospitals in Republic of Belarus
- Breastfeeding initiated at birth, with no contraindications to breastfeeding
- Apgar score >=5 at 5 minutes
- Full term gestation
- Birth weight > 2500g

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01561612
Belarus | |
Maternal and Child Health Center | |
Minsk, Belarus |
Principal Investigator: | Emily Oken, MD | Harvard Pilgrim Health Care | |
Principal Investigator: | Richard M Martin, MD | University of Bristol |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Emily Oken, Associate Professor, Harvard Pilgrim Health Care |
ClinicalTrials.gov Identifier: | NCT01561612 |
Other Study ID Numbers: |
190250 R01HD050758 ( U.S. NIH Grant/Contract ) FOOD-DT-2005-007036 ( Other Identifier: European Union's project on Early Nutrition Programming: Long-term Efficacy and Safety Trials ) G0600705 ( Other Grant/Funding Number: UK Medical Research Council ) K24HD069408 ( U.S. NIH Grant/Contract ) MOP-53155 ( Other Grant/Funding Number: Canadian Institutes of Health Research ) |
First Posted: | March 23, 2012 Key Record Dates |
Last Update Posted: | October 10, 2013 |
Last Verified: | October 2013 |
Breastfeeding Child Health Obesity Blood Pressure Asthma |
Cognitive Development Behavior Eczema Lung Function Spirometry |